Mr. Zhanghang Yan is a Vice President at Quan Capital, based in Shanghai. Prior to joining Quan Capital, he spent four years at SDIC Venture Capital as an associate, taking on increasing responsibilities and focusing on cutting-edge biotech and IVD. At Quan, he played an integral role in generating new investment ideas and portfolio management. He has extensive experience conducting healthcare industry research, performing due diligence, and structuring deals. He has played important role with Quan’s investment in multiple biotech companies across various modalities and disease areas, including Therorna (Board observer), Adcentrx (Board observer), and Windward Bio.
Zhanghang received his B.S. degree in Biology from Nanjing University and a Master of Science degree in Genetics and Genomics from University of California, Davis.